Crossmark

Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles

Crossref DOI link: https://doi.org/10.1038/nnano.2016.135

Published Online: 2016-08-01

Published Print: 2016-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kishimoto, Takashi K.

Ferrari, Joseph D.

LaMothe, Robert A.

Kolte, Pallavi N.

Griset, Aaron P.

O'Neil, Conlin

Chan, Victor

Browning, Erica

Chalishazar, Aditi

Kuhlman, William

Fu, Fen-ni

Viseux, Nelly

Altreuter, David H.

Johnston, Lloyd

Maldonado, Roberto A.
License Information

Text and Data Mining valid from 2016-08-01
More Information

Article History

Received: 15 September 2015

Accepted: 22 June 2016

First Online: 1 August 2016

Competing interests

: All authors are employees and shareholders of Selecta Biosciences.